Evidence map›Paper›PMID 41732686›Full record

ArticleThe journal of allergy and clinical immunology. Global2026

A computational phenotype for difficult-to-treat asthma with corticosteroid overuse using electronic health care records.

Nikki C C Werkman, Angelique Egberts, Youssra Bais, Toine van Rijthoven, Yasemin Türk, Esther Vis, Gert-Jan Braunstahl, Erwin C Vasbinder

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nikki C C WerkmanDepartment of Clinical Pharmacy, Franciscus, Rotterdam and Schiedam, The Netherlands.
Angelique EgbertsDepartment of Clinical Pharmacy, Franciscus, Rotterdam and Schiedam, The Netherlands.
Youssra BaisDepartment of Clinical Pharmacy, Franciscus, Rotterdam and Schiedam, The Netherlands.
Toine van RijthovenBusiness Intelligence, Franciscus, Rotterdam and Schiedam, The Netherlands.
Yasemin TürkDepartment of Respiratory Medicine, Franciscus, Rotterdam and Schiedam, The Netherlands.
Esther VisDepartment of Respiratory Medicine, Admiraal de Ruyter hospital, Goes and Vlissingen, The Netherlands.
Gert-Jan BraunstahlDepartment of Respiratory Medicine, Franciscus, Rotterdam and Schiedam, The Netherlands.
Erwin C VasbinderDepartment of Clinical Pharmacy, Franciscus, Rotterdam and Schiedam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with difficult-to-treat asthma experience insufficient symptom control despite intensive treatment, leading to overuse of oral corticosteroids (OCSs), which is associated with high patient and economic burden. Many of these remain unnoticed, even by their pulmonologist. Objective: We sought to create a query, also known as computational phenotype, identifying patients with difficult-to-treat asthma to facilitate their access to treatment optimalization. Methods: We used electronic health care records from 2 Dutch hospitals: Franciscus and Admiraal de Ruyter Hospital (Adrz) from the year 2023. We included adult patients with at least 1 hospital visit for asthma. The query was built using Structured Query Language code with data from Franciscus and subsequently applied to data in Franciscus and Adrz. Performance was scored by manual evaluation of the patient records by a pulmonologist and a pharmacist. Results: We included 1217 (Franciscus) and 267 (Adrz) patients. The query classified patients as having difficult-to-treat asthma when they had used high-dose inhaled corticosteroids during at least 90 days and had either received at least 2 courses of high-dose OCSs, or at least 90 days of low-dose OCSs in 2023. The sensitivity, specificity, positive predictive value, and negative predictive value were 0.75, 0.76, 0.63, and 0.85 in Franciscus, and 0.40, 0.95, 0.80, and 0.78 in Adrz, respectively. Conclusions: The query is an efficient way of identifying patients with difficult-to-treat asthma and OCS overuse.

Indexed as

Asthmabiologicalcomputational phenotypeoral corticosteroidsquery

Identifiers

PMID41732686
PMCPMC12925309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.